The Role of Peri-operative Chemotherapy for Resectable Colorectal Liver Metastasis: What Does the Evidence Support?

被引：9
|
作者：
Pawlik, Timothy M. [1 ]
Cosgrove, David [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med Oncol, Baltimore, MD 21287 USA
来源：
JOURNAL OF GASTROINTESTINAL SURGERY | 2011年 / 15卷 / 03期
关键词：
FLUOROURACIL PLUS LEUCOVORIN; III COLON-CANCER; HEPATIC RESECTION; ADJUVANT TREATMENT; PREOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; PHASE-III; SURVIVAL;
D O I：
10.1007/s11605-011-1423-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：410 / 415
页数：6
相关论文
共 50 条
  • [31] Prognostic significance of perioperative chemotherapy on resectable colorectal mucinous adenocarcinoma liver metastasis
    Li, Cong
    Su, Dongfang
    Peng, Jianhong
    Fang, Yujing
    Zhou, Wenhao
    Li, Shaohua
    Luo, Baojia
    Wan, Desen
    Pan, Zhizhong
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (05) : 690 - 697
  • [32] Neoadjuvant chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a systematic review of comparative studies
    Nigri, Giuseppe
    Petrucciani, Niccolo
    Ferla, Fabio
    La Torre, Marco
    Aurello, Paolo
    Ramacciato, Giovanni
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2015, 13 (02): : 83 - 90
  • [33] Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
    Kosuke Ono
    Tomoyuki Abe
    Akihiko Oshita
    Yusuke Sumi
    Takuya Yano
    Hiroshi Okuda
    Manabu Kurayoshi
    Tsuyoshi Kobayashi
    Hideki Ohdan
    Toshio Noriyuki
    Masahiro Nakahara
    World Journal of Surgical Oncology, 19
  • [34] Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
    Ono, Kosuke
    Abe, Tomoyuki
    Oshita, Akihiko
    Sumi, Yusuke
    Yano, Takuya
    Okuda, Hiroshi
    Kurayoshi, Manabu
    Kobayashi, Tsuyoshi
    Ohdan, Hideki
    Noriyuki, Toshio
    Nakahara, Masahiro
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [35] Phase 2 Peri-Operative Study of Fianlimab plus Cemiplimab plus Chemotherapy vs Cemiplimab plus Chemotherapy in Resectable EarlyStage NSCLC
    Paz-Ares, L.
    Girard, N.
    Spira, A.
    Chaudhry, U.
    Ghattas, M.
    Li, S.
    Salvati, M.
    Lowy, I.
    Fury, M. G.
    Paoluzzi, L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S377 - S378
  • [36] Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey
    Rong, Zhixia
    Martel, Guillaume
    Vandenbroucke-Menu, Franck
    Adam, Rene
    Lapointe, Real
    HPB, 2014, 16 (04) : 342 - 349
  • [37] Patterns of peri-operative systemic therapy in liver-limited metastatic colorectal cancer (mCRC)
    Kellock, Trenton Tyler
    Renouf, Daniel John
    Speers, Caroline
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Pen-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis
    Wang, Z. -M.
    Chen, Y. -Y.
    Chen, F. -F.
    Wang, S. -Y.
    Xiong, B.
    EJSO, 2015, 41 (09): : 1197 - 1203
  • [39] Role of chemotherapy in resectable liver metastases from colorectal cancer: food for thought from pooled evidence
    Mauri, Davide
    Filis, Panagiotis
    Tsali, Lampriani
    Zarkavelis, George
    Pentheroudakis, George
    ESMO OPEN, 2018, 3 (04)
  • [40] Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC)
    Gawdi, Rohin
    Valenzuela, Cristian D.
    Moaven, Omeed
    Stauffer, John A.
    Del Piccolo, Nico R.
    Cheung, Tanto
    Corvera, Carlos U.
    Wisneski, Andrew D.
    Cha, Charles
    Shen, Perry
    Russell, Greg
    Zarandi, Nima
    Dourado, Justin
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (02) : 339 - 347
12345